Nautilus Biotechnology files declaratory judgment suit against Somalogic and Caltech over patent non-infringement

Nautilus Biotechnology, Inc.

Filed suit on Dec 14, 2023 in Northern District of California against Somalogic and Caltech.
Seeks declaration that Nautilus does not infringe US Patent No. 7,842,793 related to DNA origami structures.
Somalogic alleged Nautilus' Proteome Analysis Platform infringes the '793 patent; Nautilus denies using any claimed technology.
Company states it has no plans to use the patent's technology in current or future products.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.